Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Hair loss doesn't affect COVID-19 severity.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

Testosterone may both worsen and protect against COVID-19 effects in men.

ADAM17 could be a potential target for treating PCOS.

Long COVID patients may have hormonal imbalances linked to their symptoms.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

COVID-19 can cause or worsen skin issues.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Using existing drugs for new treatments is cost-effective and safer.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Systemic retinoids do not increase COVID-19 risk or severity.

Post-COVID-19 syndrome is complex, affects 5%-10% of people, and requires better research and global collaboration for treatment.

Vaccination helps reduce long COVID symptoms in women with PCOS.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Vaccination is the most effective way to reduce COVID-19 transmission.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.